Internet Explorer is not supported. Please use a modern browser like Chrome, Firefox, or Edge to access this app.
Hair Loss
Take our hair loss quiz
Get a recommendation tailored for your needs
Explore
Treatments
Sexual Health
Medication Overview
Minoxidil 8%, Cetirizine HCl 1%, Latanoprost 0.005%, Dutasteride 0.25%, Finasteride 0.01%, Melatonin 0.1%, Caffeine 0.2%, Tretinoin 0.001%, Vitamin D3 1,000 IU/mL, Biotin 0.2%

Keeps Gel+ is a unique 10-in-1 compounded topical formula designed to combat hair loss and promote healthy hair growth through multiple pathways. The formula includes several prescription-strength medications that work together to target male pattern hair loss:
Gel+ also contains additional ingredients selected to support hair growth and scalp and follicle health:
Gel+ combines ingredients that address male pattern hair loss through several complementary pathways. Minoxidil stimulates hair follicles, while dutasteride and finasteride reduce the effects of DHT, the hormone that contributes to progressive follicle miniaturization in male pattern hair loss. Latanoprost supports the hair-growth cycle, while the additional ingredients provide support for follicular activity, minoxidil response, and scalp and hair health.
Some temporary shedding may occur during the first 3–6 weeks after starting treatment. This can occur with minoxidil treatment and does not necessarily mean the medication isn’t working. Early improvement may be noticed after approximately 3–4 months, with more meaningful results typically seen within 6–12 months. Continued treatment is needed to maintain the benefits, and hair gains will likely diminish if treatment is discontinued.
Gel+ should not be used by patients with a history of heart disease, other than high blood pressure. Please tell your Keeps provider if you have ever had a heart condition.
The most common side effects are related to the scalp and may include dryness, scaling, itching, redness, burning, irritation, or allergic reactions. Unwanted facial or body hair can occur if the medication is accidentally transferred outside the treatment area.
While oral dutasteride can cause systemic side effects, including sexual dysfunction and mood changes such as depression or suicidal thoughts, limited early studies suggest topical dutasteride may have a lower risk of systemic side effects than oral treatment. However, the safety and systemic absorption of this specific compounded Gel+ formulation have not been established. For more information, see the Oral Dutasteride Prescribing Information.
Although uncommon, topical medications can be absorbed through the skin. Stop using Gel+ and contact the clinical team if you develop significant scalp irritation, swelling, blistering or rash; dizziness or fainting; palpitations; chest pain; shortness of breath; rapid weight gain; swelling of the legs or face; new sexual symptoms; breast tenderness or enlargement; or new mood symptoms such as depression, suicidal thoughts, or anxiety.
Do not donate blood while using Gel+ and for at least 6 months after stopping treatment. Gel+ contains dutasteride, which may harm a developing male fetus if transferred through donated blood.
Gel+ is a compounded medication that is not FDA-approved. Its combination of ingredients has not been evaluated by the FDA for safety or effectiveness, and some ingredients are used off-label to treat hair loss. Although topical minoxidil 5% is FDA-approved for hair loss, the 8% concentration in Gel+ is not FDA-approved.
Keep in the loop
Thanks! You've signed up successfully.